Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aytu BioScience, Inc.

1.09
-0.0250-2.25%
Post-market: 1.090.00000.00%17:08 EDT
Volume:9.40K
Turnover:10.20K
Market Cap:6.69M
PE:-0.57
High:1.11
Open:1.10
Low:1.06
Close:1.11
Loading ...
Mar 25, 2020

Major Issues Report

Current report, item 3.01
Mar 23, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Mar 23, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 20, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Mar 19, 2020

Major Issues Report

Current report, item 8.01
Mar 13, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 13, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Mar 13, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Mar 12, 2020

Major Issues Report

Current report, item 8.01
Mar 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Feb 26, 2020

Major Issues Report

[Amend] Current report, item 9.01
Feb 24, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Feb 21, 2020

Major Issues Report

Current report, item 3.01
Feb 20, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 14, 2020

Major Issues Report

Current report, items 1.01, 2.01, 3.02, and 9.01
Feb 14, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 14, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Major Issues Report

Current report, items 2.02 and 9.01